Page 24 - Ipca Laboratories News Today

Indian equities saw ferocious selling by foreign institutional investors (FIIs) amid the ongoing global economic concerns of crude and gas price hikes, rising inflation, and currency depreciation against the US dollar. Only in the first eight months of 2022 till August 31, FIIs have sold shares worth Rs 2.68 lakh crore in the Indian equity market.

Indian pharmaceutical maker Ipca Laboratories Limited, parent company of Pisgah Labs in Western North Carolina, says it will spend $55 million to expand its manufacturing product line at the Transylvania County facility.

Pisgah Laboratories, Inc., a pharmaceutical manufacturer, will add 57 new jobs in Transylvania County, Governor Roy Cooper announced today.

Pharmaceutical manufacturer Pisgah Laboratories, Inc., has announced a $55 million multi-phase expansion in Transylvania County, which will create at least 55 new local jobs by the year 2026.

Pharmaceutical manufacturer Pisgah Laboratories, Inc., has announced a $55 million multi-phase expansion in Transylvania County, which will create at least 55 new local jobs by the year 2026.

The Business Research Company’s COVID-19 Current Therapy Market 2022 – Opportunities And Strategies – Global Forecast To 2030

IPCA Ratlam unit head Dinesh Siyal informed that IPCA Laboratories invested Rs.40 crore last year under the environment head besides spending every year Rs 12 crore to Rs 14 crore for proper environment maintenance and management.

Stock markets open on a lacklustre note: Sensex up, Nifty above 16,200

/PRNewswire/ -- Coronavirus (COVID-19) current therapy market segmentation is done by drug type into antiviral, monoclonal antibodies, corticosteroid,...

The COVID therapy market includes drugs in the form of antivirals, MAbs, and more. However, the market is set to see decline in the forecast period. LONDON, March 15, 2022 /PRNewswire/